Drug Type Peptide Conjugate Radionuclide, Diagnostic radiopharmaceuticals |
Synonyms (18F)-2-fluoropropionyl-labeled PEGylated dimeric arginine-glycine-aspartic acid peptide, 104150(Stanford University), 2-fluoropropionyl-labeled pegylated dimeric RGD peptide + [2] |
Target |
Mechanism αvβ3 modulators(Integrin alpha-V/beta-3 modulators), PET imaging(Positron-emission tomography enhancers) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Achalasia Addisonianism Alacrimia Syndrome | Phase 2 | US | 31 Oct 2019 | |
Aortic Aneurysm, Abdominal | Phase 2 | US | 31 Oct 2019 | |
Carotid Artery Diseases | Phase 2 | US | 31 Oct 2019 | |
Stroke | Phase 2 | US | 31 Oct 2019 | |
Acidemia, Isovaleric | Phase 2 | US | 04 Mar 2013 | |
Breast Cancer 3 | Phase 2 | US | 04 Mar 2013 | |
Glioblastoma | Phase 2 | US | 04 Mar 2013 | |
Gliosarcoma | Phase 2 | US | 04 Mar 2013 | |
Granuloma, Lethal Midline | Phase 2 | US | 04 Mar 2013 | |
Hypopharyngeal Carcinoma | Phase 2 | US | 04 Mar 2013 |
Phase 1/2 | 25 | (Glioblastoma Multiforme (GBM)) | thyzgvxmgp(gvgxyfwiad) = tcqtdligcd xzpjcdaesa (kwaiywelta, eyrkrcrvui - hrhtsfdyut) View more | - | 06 Sep 2019 | ||
(Gynecological Cancers) | thyzgvxmgp(gvgxyfwiad) = desqgbrsey xzpjcdaesa (kwaiywelta, sfuitmmcrj - gfacftfukr) View more |